Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 10,830 shares at $35.93 ($391K) on 2014-08-18, disclosed to the SEC on 2014-08-19.
Scheduled sale ($391k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.93 | 4,031 | $145K | 37.1% |
| 2 | $35.93 | 4,199 | $151K | 38.6% |
| 3 | $36.52 | 1,274 | $47K | 11.9% |
| 4 | $36.52 | 1,326 | $48K | 12.4% |
| Total | $36.07 avg | 10,830 | $391K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |